Thursday 3rd December 2009 |
Text too small? |
Auckland house prices edged up to a 23-month high in November as new listings held above 1,600 and demand was underpinned by stronger migration.
The average sale price rose 1% to $550,217 last month from October, according to Barfoot & Thompson, the city’s biggest real estate firm. Prices are 9.9% higher than November 2008.
“The level of activity and strength of prices in the housing market is a strong signal that in Auckland at least, property has returned to being seen as a sound, medium- to long-term investment option,” said managing director Peter Thompson, in a statement. “While low interest rates are a factor, buyers are committing on the basis of the property meeting their checklists and views about value for money.”
New Zealanders are still optimistic about the state of the housing market, with the majority of respondents in an ASB survey last month saying now is a good time to buy a house.
Property prices hit a 10-year high for the month of October, according to Real Estate Institute data, and the revival in the market has been underpinned the country’s economic recovery. Still, the Reserve Bank said in its Financial Stability Report house prices are high relative to incomes and this “may limit scope for a sustained rise.”
For the second month in a row Barfoot listed more than 1,600 new properties, helping keep the number of properties for sale above 5,600, the highest number of available listings since May.
The real estate agency sold 862 houses in November, down 1% from October, and up 58% from the same month a year earlier.
In its property management division the average weekly rent achieved fell 1.2% to $397 last month from October, and was up 4.2% from the same time in 2008. The company let 676 properties compared to 760 a month earlier.
Businesswire.co.nz
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report